Live·Open questions in longevity research
← Questions

In people with age-related immune dysfunction, what conditions are necessary and jointly sufficient to durably restore key functions of innate and adaptive immunity to levels within the ranges observed in healthy young adults, while preserving protective immunological memory, self-tolerance, and control of latent infections?

Can stronger existing antibodies broaden protection, and does disconnecting trained helper cells reverse that gain across repeated exposures?

Antibodies can cover a target that an antibody-producing cell would otherwise recognize. S2 reports that this can limit established memory cells' access to the target and their ability to compete for help from other immune cells.

The whole reason

If that restriction leaves opportunities for cells recognizing unfamiliar targets, protection could broaden; if it blocks useful responses without replacement, protection could instead be constrained. Mistaking either outcome for the other would misrepresent whether stronger existing antibodies preserve familiar protection, expand unfamiliar protection, or compromise one while changing the other. The question therefore depends on both the direction of the change and whether it persists through repeated encounters.

The question in full

The question concerns whether older people whose immune defenses have weakened can regain protection against unfamiliar targets while keeping protection learned from earlier encounters. It asks whether stronger antibodies already present before an exposure allow previously untrained antibody-producing cells to respond to unfamiliar targets, rather than reinforcing responses to familiar ones. It also asks whether separating those responses from the assistance provided by memory helper T cells reverses any benefit over repeated exposures, compared with leaving that assistance connected. The question assumes that antibodies covering recognizable targets can either relieve competition from established responses or exclude useful responses, and that remembered helper signals can restore established responses' access. Its stated success condition is recovery of unfamiliar protection into the healthy-young-adult range between exposures, with established protection remaining above its required limits for ten years; the supplied material does not define those ranges or limits.

Competing hypotheses

These hypotheses propose different mechanisms. Comparing their predictions helps identify observations that could distinguish them.

  1. 01Memory helper cells can sustain recall responses without the responding cells presenting antigenIn aged-donor lymphoid cultures, memory follicular helper T cells may let recall B cells outcompete unfamiliar responses despite antibody masking. Repeated selection and descendant production by recall cells lacking surface HLA-II would test whether help bypasses recipient antigen presentation.
  2. 02Repeated pulling on antibody-bound deposits governs which immune responses can growOn follicular dendritic cells, repeated B-cell pulling is proposed to damage antibody-bound antigen deposits, first helping unfamiliar responses and then blocking them. A decisive observation would be an effect of prior pulling that survives replacement of all lymphocytes and resets when the presentation layer is repaired.
  3. 03Antibodies redirect immune help by changing how captured proteins are broken downAntibodies favor unfamiliar protective responses by changing which protein fragments B cells display to helper cells. Changing protein cleavage sites should reverse this benefit; directly supplying the helper fragment should erase the difference while antibody masking remains.
Each entry represents a published hypothesis. Where no hypotheses are published yet, the entries show possible answers to the scientific question.

What results would tell us about the hypotheses

Choose a possible result to see which hypothesis it would support, what the alternatives predict, and what would need to be tested next.

If we observe
In aged-donor lymphoid cultures, establish barcoded recall B cells and then inducibly remove their HLA-II expression, verifying loss of both endogenous and acquired surface HLA-II. Independently activate memory Tfh cells through antigen-bearing non-B APCs. At high familiar-epitope antibody occupancy, this hypothesis predicts continued multicycle participation and differentiated output from HLA-II-negative recall B cells, accompanied by reduced functional output from unfamiliar founders. Recipient-specific CD40 blockade should eliminate that rescue. The mechanical and processing rivals predict that physiological helper-mediated rescue still requires recipient B-cell presentation. Transient survival or extrafollicular proliferation alone would not confirm this hypothesis. Hypothetical result
Would support the hypothesis
Memory helper cells can sustain recall responses without the responding cells presenting antigen — In aged-donor lymphoid cultures, memory follicular helper T cells may let recall B cells outcompete unfamiliar responses despite antibody masking. Repeated selection and descendant production by recall cells lacking surface HLA-II would test whether help bypasses recipient antigen presentation.
Other hypotheses predict
  • Repeated pulling on antibody-bound deposits governs which immune responses can grow — At matched antibody occupancy, antigen inventory, accessible epitope density and helper activation, physically precycled antigen-presenting surfaces should alter unfamiliar founder output after all original lymphocytes are replaced. Moderate precycling should improve extraction by unfamiliar founders; greater precycling should reverse the benefit. Repairing or replacing the presentation layer should reset the effect without changing antibody specificity. Disrupting mechanical connectivity while preserving epitope geometry should abolish the cycle-history dependence. Neither the recipient-licensing hypothesis nor the processing hypothesis predicts a transferable, acellular damage history under those controls.
  • Antibodies redirect immune help by changing how captured proteins are broken down — At matched native epitope occupancy, antigen uptake and surface mechanics, changing only protease-sensitive sequences flanking the helper determinant should reverse the antibody-dose effect on unfamiliar protective output. The reversal must track measured peptide–HLA-II abundance. Loading defined helper peptide directly onto recipient B cells to equalize presentation should eliminate the processing-dependent difference while leaving antibody masking intact. Recipient HLA-II removal should abolish helper rescue. These outcomes distinguish peptide production from both recipient-presentation bypass and persistent mechanical damage.
What to check next
In older humans, do stronger pre-existing antibodies increase or decrease protection against unfamiliar targets across repeated exposures, and does separating memory helper T-cell assistance change that direction?

These are hypothetical results. Selecting one shows what would follow from it; it does not confirm a hypothesis or change its assessment.

Comparing hypotheses

Compare the proposed mechanisms, the predictions that distinguish the hypotheses, and the observations that would count against each one.

01

Memory helper cells can sustain recall responses without the responding cells presenting antigen

Information and sensing
Proposed mechanism

In aged-donor lymphoid cultures, memory follicular helper T cells may let recall B cells outcompete unfamiliar responses despite antibody masking.

Full text

Strong pre-existing antibody can reopen unfamiliar responses by masking familiar epitopes, but this benefit is reversed when activated memory Tfh cells license neighboring recall B cells without requiring antigen presentation by those recipient B cells. The proposed mechanism is sustained, recipient-MHC-II-independent CD40L and cytokine licensing, rather than ordinary help delivered after weak but sufficient antigen capture. Repeated exposure maintains a local permissive helper field in which previously activated recall cells retain a competitive advantage despite antibody masking. Restricting help to cognate B-cell presentation would stabilize SPV_7 while preserving established protective antibody output.

What distinguishes its prediction

In aged-donor lymphoid cultures, establish barcoded recall B cells and then inducibly remove their HLA-II expression, verifying loss of both endogenous and acquired surface HLA-II.

Full text

Independently activate memory Tfh cells through antigen-bearing non-B APCs. At high familiar-epitope antibody occupancy, this hypothesis predicts continued multicycle participation and differentiated output from HLA-II-negative recall B cells, accompanied by reduced functional output from unfamiliar founders. Recipient-specific CD40 blockade should eliminate that rescue. The mechanical and processing rivals predict that physiological helper-mediated rescue still requires recipient B-cell presentation. Transient survival or extrafollicular proliferation alone would not confirm this hypothesis.

What would weaken the hypothesis

Repeated pulling on antibody-bound deposits governs which immune responses can grow predicts instead: At matched antibody occupancy, antigen inventory, accessible epitope density and helper activation, physically precycled antigen-presenting surfaces should alter unfamiliar founder output after all original lymphocytes are replaced.

Full text

Moderate precycling should improve extraction by unfamiliar founders; greater precycling should reverse the benefit. Repairing or replacing the presentation layer should reset the effect without changing antibody specificity. Disrupting mechanical connectivity while preserving epitope geometry should abolish the cycle-history dependence. Neither the recipient-licensing hypothesis nor the processing hypothesis predicts a transferable, acellular damage history under those controls.

Antibodies redirect immune help by changing how captured proteins are broken down predicts instead: At matched native epitope occupancy, antigen uptake and surface mechanics, changing only protease-sensitive sequences flanking the helper determinant should reverse the antibody-dose effect on unfamiliar protective output. The reversal must track measured peptide–HLA-II abundance. Loading defined helper peptide directly onto recipient B cells to equalize presentation should eliminate the processing-dependent difference while leaving antibody masking intact. Recipient HLA-II removal should abolish helper rescue. These outcomes distinguish peptide production from both recipient-presentation bypass and persistent mechanical damage.

02

Repeated pulling on antibody-bound deposits governs which immune responses can grow

Structure and topology
Proposed mechanism

On follicular dendritic cells, repeated B-cell pulling is proposed to damage antibody-bound antigen deposits, first helping unfamiliar responses and then blocking them.

Full text

The antibody–helper switch is governed by cyclic fracture of a mechanically connected, antibody-crosslinked antigen deposit on FDCs. Strong antibody initially masks familiar epitopes but also strengthens the deposit against extraction. Repeated B-cell pulling subsequently creates and propagates local detachment fronts. Limited fracture releases extractable antigen patches that permit unfamiliar founders to establish; extensive delamination destroys that permissive presentation geometry. Uncoupled memory help reverses the initial benefit by sustaining otherwise poorly selected recall cells long enough to increase local pulling cycles and drive deposits beyond the permissive fracture window. Mechanical damage retained between exposures, rather than antibody concentration alone, determines whether SPV_7 remains stable.

What distinguishes its prediction

At matched antibody occupancy, antigen inventory, accessible epitope density and helper activation, physically precycled antigen-presenting surfaces should alter unfamiliar founder output after all original lymphocytes are replaced.

Full text

Moderate precycling should improve extraction by unfamiliar founders; greater precycling should reverse the benefit. Repairing or replacing the presentation layer should reset the effect without changing antibody specificity. Disrupting mechanical connectivity while preserving epitope geometry should abolish the cycle-history dependence. Neither the recipient-licensing hypothesis nor the processing hypothesis predicts a transferable, acellular damage history under those controls.

What would weaken the hypothesis

Memory helper cells can sustain recall responses without the responding cells presenting antigen predicts instead: In aged-donor lymphoid cultures, establish barcoded recall B cells and then inducibly remove their HLA-II expression, verifying loss of both endogenous and acquired surface HLA-II.

Full text

Independently activate memory Tfh cells through antigen-bearing non-B APCs. At high familiar-epitope antibody occupancy, this hypothesis predicts continued multicycle participation and differentiated output from HLA-II-negative recall B cells, accompanied by reduced functional output from unfamiliar founders. Recipient-specific CD40 blockade should eliminate that rescue. The mechanical and processing rivals predict that physiological helper-mediated rescue still requires recipient B-cell presentation. Transient survival or extrafollicular proliferation alone would not confirm this hypothesis.

Antibodies redirect immune help by changing how captured proteins are broken down predicts instead: At matched native epitope occupancy, antigen uptake and surface mechanics, changing only protease-sensitive sequences flanking the helper determinant should reverse the antibody-dose effect on unfamiliar protective output. The reversal must track measured peptide–HLA-II abundance. Loading defined helper peptide directly onto recipient B cells to equalize presentation should eliminate the processing-dependent difference while leaving antibody masking intact. Recipient HLA-II removal should abolish helper rescue. These outcomes distinguish peptide production from both recipient-presentation bypass and persistent mechanical damage.

03

Antibodies redirect immune help by changing how captured proteins are broken down

Proteolytic epitope encoding
Proposed mechanism

Antibodies favor unfamiliar protective responses by changing which protein fragments B cells display to helper cells.

Full text

Antibody changes the helper-peptide identity produced from captured antigen, rather than primarily changing which B cells can bind its surface. Bound antibody protects selected protein regions during endosomal proteolysis, suppressing some helper determinants and preserving others. Strong antibody reopens unfamiliar protective responses when the resulting peptide–HLA-II profile favors help to unfamiliar founders; uncoupling or repositioning familiar helper determinants restores productive presentation by recall cells and reverses the benefit. Repeated exposure reinforces this cleavage-dependent routing while the relevant antibody–antigen complexes recur. Controlling peptide generation, rather than increasing global help, would stabilize SPV_7.

What distinguishes its prediction

At matched native epitope occupancy, antigen uptake and surface mechanics, changing only protease-sensitive sequences flanking the helper determinant should reverse the antibody-dose effect on unfamiliar protective output.

Full text

The reversal must track measured peptide–HLA-II abundance. Loading defined helper peptide directly onto recipient B cells to equalize presentation should eliminate the processing-dependent difference while leaving antibody masking intact. Recipient HLA-II removal should abolish helper rescue. These outcomes distinguish peptide production from both recipient-presentation bypass and persistent mechanical damage.

What would weaken the hypothesis

Memory helper cells can sustain recall responses without the responding cells presenting antigen predicts instead: In aged-donor lymphoid cultures, establish barcoded recall B cells and then inducibly remove their HLA-II expression, verifying loss of both endogenous and acquired surface HLA-II.

Full text

Independently activate memory Tfh cells through antigen-bearing non-B APCs. At high familiar-epitope antibody occupancy, this hypothesis predicts continued multicycle participation and differentiated output from HLA-II-negative recall B cells, accompanied by reduced functional output from unfamiliar founders. Recipient-specific CD40 blockade should eliminate that rescue. The mechanical and processing rivals predict that physiological helper-mediated rescue still requires recipient B-cell presentation. Transient survival or extrafollicular proliferation alone would not confirm this hypothesis.

Repeated pulling on antibody-bound deposits governs which immune responses can grow predicts instead: At matched antibody occupancy, antigen inventory, accessible epitope density and helper activation, physically precycled antigen-presenting surfaces should alter unfamiliar founder output after all original lymphocytes are replaced. Moderate precycling should improve extraction by unfamiliar founders; greater precycling should reverse the benefit. Repairing or replacing the presentation layer should reset the effect without changing antibody specificity. Disrupting mechanical connectivity while preserving epitope geometry should abolish the cycle-history dependence. Neither the recipient-licensing hypothesis nor the processing hypothesis predicts a transferable, acellular damage history under those controls.

No test is published for this question yet

The hypotheses above state the observations that could distinguish them. A proposed experiment for this question has not yet been published.

What to check next: In older humans, do stronger pre-existing antibodies increase or decrease protection against unfamiliar targets across repeated exposures, and does separating memory helper T-cell assistance change that direction?

Every proposed test →

What the literature settles, and what it does not

The sources read against this question, the assumption it rests on, and the verdict that follows.

Can stronger existing antibodies broaden protection, and does disconnecting trained helper cells reverse that gain across repeated exposures?

What this question is asking

The question concerns whether older people whose immune defenses have weakened can regain protection against unfamiliar targets while keeping protection learned from earlier encounters. It asks whether stronger antibodies already present before an exposure allow previously untrained antibody-producing cells to respond to unfamiliar targets, rather than reinforcing responses to familiar ones. It also asks whether separating those responses from the assistance provided by memory helper T cells reverses any benefit over repeated exposures, compared with leaving that assistance connected. The question assumes that antibodies covering recognizable targets can either relieve competition from established responses or exclude useful responses, and that remembered helper signals can restore established responses' access. Its stated success condition is recovery of unfamiliar protection into the healthy-young-adult range between exposures, with established protection remaining above its required limits for ten years; the supplied material does not define those ranges or limits.

What the terms mean
Antibody and pre-existing antibody strength
An antibody is an immune protein that binds a particular recognizable target. Pre-existing antibodies are present before the exposure being considered; 'strength' is not defined by a measurement in the supplied input.
Exposure
An encounter with material that the immune system can recognize, including vaccination or infection. The question concerns what changes over successive encounters.
Antigen and epitope
An antigen is material recognized by the immune system; an epitope is a particular recognizable part of that material. Antibodies can cover an epitope and limit a cell's access to it.
B cell, naive B cell, and memory B cell
B cells are immune cells that can give rise to antibody-secreting cells. Naive B cells have not previously been activated by their matching target, whereas memory B cells persist after an earlier response and can participate again; these names describe experience, not whether a response will be protective.
Antibody-secreting cell
A cell that releases antibodies. S1 reports a response by a form of these cells called plasmablasts after the second vaccination.
Memory helper T cell and helper signals
Helper T cells are immune cells that assist other immune cells; memory helper cells remain from earlier responses. Their assistance is the connection the question proposes separating, although the supplied input does not specify how.
Follicular helper T cell
A type of helper T cell that assists B cells during antibody responses. S2 describes competition among B cells for this help, without establishing that the helpers involved are the memory helpers specified by the question.
Germinal center
A site within immune tissue where responding B cells undergo selection during an antibody response. S2 concerns how antibody blocking changes memory B cells' participation in these sites.
Antibody feedback and masking
Antibody feedback means that antibodies already present influence subsequent immune responses. Masking is one possible route: antibodies cover recognizable targets, which can exclude cells needing those targets and potentially reduce competition faced by cells recognizing other targets.
Recruitment, allocation, and recall
Recruitment means cells joining a response; allocation refers here to how participation is distributed between established and unfamiliar responses. Recall is the reuse of immune responses learned through earlier encounters.
Unfamiliar functional coverage
The range of previously unfamiliar targets against which an immune response provides useful protection. Recognizing a target or recruiting cells does not, by itself, establish that protection.
Young-reference band and protection limits
The young-reference band is the range of immune function measured in healthy young adults that the pipeline uses as its recovery benchmark. Protection limits are its proposed minimum acceptable levels of established protection; neither is numerically defined in the supplied material.
Original antigenic sin
A name for the tendency of earlier immune experience to favor responses to familiar targets when related but changed targets are encountered. It describes a pattern of response, not an inevitable outcome of every exposure.
Influenza and vaccine strain
Influenza is a viral infection. A vaccine strain is the particular version of the virus represented in a vaccine, which matters because familiar and unfamiliar target regions can differ between versions.
Genetic changes associated with prior B-cell experience
Changes in antibody-producing genes can accumulate as B-cell responses develop. S1 uses the small extent of such changes in the reported antibodies as evidence supporting an origin in previously untrained B cells.
Cell culture, carrier, and hapten
Cell culture studies examine cells outside a living organism; S10 used mouse cells. A hapten is a small recognizable target attached to a larger carrier, allowing that study to distinguish effects of antibodies against the attached target from effects against the carrier.
Dynamic model
A representation of how a system changes over time. S7 models responses to successive infections; its reported result is not a direct observation of the antibody-and-helper intervention at issue.
Age-related immune dysfunction
Reduced or altered immune performance associated with aging. The question concerns older people with such dysfunction, rather than assuming identical immune function in all older people.
Innate and adaptive immunity
Innate immunity provides broadly responsive defenses, while adaptive immunity develops target-specific responses and memory. The broader pipeline objective includes both, but the immediate question concerns antibodies and remembered cellular assistance within adaptive immunity.
Self-tolerance and latent infections
Self-tolerance is the restraint that keeps immune responses from attacking the body's own components. Latent infections persist without continuously causing active disease; preserving restraint and control of those infections belongs to the broader objective but is not established by the supplied evidence.
RL-1
An unexplained label attached to masking mechanisms in the pipeline's gap description. The supplied material provides no expansion or definition.
What the question takes for granted
Premise only partly supported
RL-1 masking mechanisms predict both recruitment relief and exclusion; memory helper signals can rescue recall access.

Antibodies are immune proteins that bind recognizable parts of a target, sometimes covering the parts that other immune cells need to reach. The assumption is that this covering can either free opportunities for previously untrained cells or shut responses out, while helper cells trained by earlier encounters can restore access for established responses. If both mechanisms operate as assumed, the balance between antibody blocking and remembered help could determine whether protection broadens.

S2 supports a narrower mechanism: antibody blocking can restrict memory B cells' access to targets and their competition for helper signals, potentially favoring less-experienced cells. S1 reports recruitment of previously untrained cells after a second vaccination, but does not establish stronger existing antibodies as its cause. S10 reports differing effects of antibodies against different parts of an experimental target, but does not establish rescue of recall access by memory helper signals. The supplied excerpts do not establish that rescue mechanism, define RL-1, or show the complete mechanism in aged humans across repeated exposures.S1S2S10

The same question asked without the part nothing read establishes:

  • In older humans, do stronger pre-existing antibodies increase or decrease protection against unfamiliar targets across repeated exposures, and does separating memory helper T-cell assistance change that direction?
  • Across repeated exposures in older humans, how do existing antibodies and memory helper T-cell assistance affect unfamiliar protection and preservation of established protection?
What turns on the answer
  • Protection broadens, but disconnecting help reverses it Under the proposed mechanism, antibody blocking would reduce established cells' competitive advantage enough to allow unfamiliar responses to develop. If disconnecting remembered helper signals removed that gain, the broadening would depend on those signals remaining connected; antibody strength alone would not account for it.
  • Protection broadens despite disconnected help Stronger existing antibodies would allow unfamiliar protection to increase even when remembered helper assistance was separated from the response. That outcome would mean the gain does not require the particular helper connection being removed, although it would not by itself establish ten-year preservation of familiar protection.
  • Protection does not broaden If established responses continued to dominate, or antibody blocking excluded useful unfamiliar responses, stronger antibodies would not reopen the desired protection. There would then be no demonstrated broadening benefit for disconnecting helper signals to reverse.
Why it matters

Antibodies can cover a target that an antibody-producing cell would otherwise recognize. S2 reports that this can limit established memory cells' access to the target and their ability to compete for help from other immune cells. If that restriction leaves opportunities for cells recognizing unfamiliar targets, protection could broaden; if it blocks useful responses without replacement, protection could instead be constrained. Mistaking either outcome for the other would misrepresent whether stronger existing antibodies preserve familiar protection, expand unfamiliar protection, or compromise one while changing the other. The question therefore depends on both the direction of the change and whether it persists through repeated encounters.

Partly answered already

S1 establishes that previously untrained B cells can contribute after a second human vaccination. S2 supplies a mechanism by which existing antibodies can restrict established memory cells, and S10 reports antibody effects that differ according to the target recognized. These settle parts of the proposed competition mechanism, while S8 and S9 preserve the opposing finding that familiar responses can dominate. Connecting these findings into a joint antibody-and-helper explanation is an inference, not a reported demonstration. None of the supplied sources establishes that stronger antibodies cause unfamiliar protection to recover, that disconnecting memory helper assistance reverses it, or that either effect meets the older-human and ten-year requirements.S1S2S10S8S9

What the literature establishes
  • In a human influenza vaccination study, the second vaccination produced an antibody-secreting cell response against a highly variable part of the virus's surface protein. Antibodies from those cells had few of the genetic changes associated with prior experience, supporting an origin in previously untrained B cells, and mostly recognized the vaccine strain. This establishes recruitment after a repeat exposure, without establishing that stronger existing antibodies caused it.S1
  • A review reports that antibody feedback can restrict memory B-cell participation in germinal centers by blocking recognizable targets. This limits those cells' acquisition of target material and their competition for follicular helper T-cell assistance.S2
  • A mouse cell-culture study reports that antibodies against the carrier component of an experimental target had enhancing or neutral effects under the reported conditions, whereas antibodies against its attached hapten component were inhibitory. The reported direction therefore differed according to what the antibodies recognized.S10
  • An influenza study describes a hierarchy in which remembered responses against shared targets tend to dominate responses against unfamiliar target regions.S9
  • An abstract describing a dynamic model reports that memory cells had a positive effect or no effect when a later infection differed from the earlier one, depending on how similar the infections were. It does not address the joint antibody-and-helper mechanism in this question.S7
What it does not settle
  • Whether increasing pre-existing antibody strength causes unfamiliar protective responses to recover, rather than merely accompanying recruitment of previously untrained cells. The supplied material also does not specify what measurement defines antibody strength.S1S2
  • Whether separating memory helper T-cell assistance reverses any antibody-associated benefit. No supplied source reports that manipulation, and the input does not define precisely what is disconnected.S2S10
  • Whether the joint effect occurs in older humans with age-related immune dysfunction and remains consistent across repeated exposures. A human second-vaccination response, a mouse cell-culture result, and a model of different infections do not establish that population and exposure history.S1S7S10
  • Whether unfamiliar protection returns to a defined healthy-young-adult range between exposures while established protection stays above defined protection limits for ten years. Neither the numerical criteria nor evidence meeting this duration is supplied.
  • Whether any observed change in responding cells produces a meaningful increase in protection against illness, and how large that increase would be.S1S2
  • Whether this mechanism contributes to the broader stated objective of restoring innate and adaptive immunity while preserving self-tolerance and control of latent infections. The supplied evidence does not establish those outcomes.
Where the sources disagree
  • S8 describes original antigenic sin: when a recognizable target changes slightly, immunity relies on memory of the earlier infection rather than developing a response to the changed target. This conflicts with a general expectation that existing immunity automatically opens unfamiliar responses, and S9 describes a related dominance of familiar responses. However, neither source directly contradicts the specific possibility that stronger antibodies under particular helper conditions could permit broadening, because neither tests that comparison.S8S9
Sources read · 6

4 literature searches, 5 full texts, 5 abstract-only; 10 source(s) read in full against this question. A bounded search is not evidence of absence.

S1Partly answers it

Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans. · Proceedings of the National Academy of Sciences of the United States of America · 2020

“Second immunization induced a plasmablast response to the highly variable HA head region. mAbs derived from these plasmablasts exhibited minimal SHM (naive B cell origin) and largely recognized the HA head region of the immunizing H5N1 strain.”

Does not settle: This human H5N1 two-dose AS03-adjuvanted vaccine study supports recruitment of strain-specific naive B cells after a repeat exposure, alongside lower stem responses likely due to antibody blocking. It does not test whether stronger pre-existing antibody causes this effect, nor whether uncoupling memory T-cell help reverses it across repeated exposures.

S2Partly answers it

Mastering Immunity: Antibody Feedback as a Driver of Germinal Center Fate and Vaccine Responses. · European journal of immunology · 2025

“Antibody feedback can restrict memory B cell participation in GCs by blocking access of memory clones to their target epitopes, limiting their ability to acquire antigen and effectively compete for Tfh help.”

Does not settle: The text supports that antibody feedback can shift germinal-center selection toward naive or less-experienced B cells recognizing new or drifted epitopes, but it does not establish that stronger pre-existing antibody reliably reopens protective responses across repeated exposures. It also does not report an experiment that uncouples memory T-cell help or tests whether doing so reverses this effect.

S7BackgroundAbstract only

Diversity of T-cell responses. · Physical biology · 2013

“When the secondary infection is different (heterologous), the memory cells have a positive effect or no effect at all depending on the similarity of the infections.”

Does not settle: This dynamic model does not address pre-existing antibody strength, unfamiliar protective responses, uncoupling memory T-cell help, or repeated exposures.

S8Contradicts itAbstract only

Original antigenic sin: A comprehensive review. · Journal of autoimmunity · 2017

“But "original antigenic sin" implies that when the epitope varies slightly, then the immune system relies on memory of the earlier infection, rather than mount another primary or secondary response to the new epitope which would allow faster and stronger responses.”

Does not settle: This abstract does not test whether stronger pre-existing antibody can reopen unfamiliar protective responses, whether memory T-cell help can be uncoupled, or effects across repeated exposures.

S9Background

Age-specific differences in the dynamics of protective immunity to influenza. · Nature communications · 2019

“The hierarchical nature of this cross-reactivity, in which memory responses to conserved antigens tend to dominate over responses to new epitopes, is known as original antigenic sin”

Does not settle: It does not test whether stronger pre-existing antibody reopens responses to unfamiliar protective epitopes, nor whether uncoupling memory T-cell help reverses any effect across repeated exposures.

S10Partly answers itAbstract only

Antibody feedback regulation in vitro: T helper cell activation and T-B cell cooperation are not impaired by anti-carrier antibody. · European journal of immunology · 1981

“Under both conditions, anti-carrier antiserum had an enhancing or no effect; only anti-hapten antiserum or monoclonal anti-hapten antibody were inhibitory.”

Does not settle: This in-vitro mouse study does not establish reopening of unfamiliar protective responses, recall entrenchment, effects across repeated exposures, or whether uncoupling memory T-cell help reverses any benefit.

← Every open question